DR. T. Karunaharan, DR. S. Senthilvel


Introduction:The present study investigated the incidence, management and outcome of Gastroin-testinal Stromal Tumors (GIST) in KAPV medical college,Tiruchirappalli. Methods: A retrospective review of all GIST patients admitted between 2013 and 2017 was conducted. Patients' demographics, clinical presentation, tumor characteristics, radiological, pathological and immunohistochemical findings, surgical procedures, recurrence and mortality were recorded. Results: A total of 4 GIST patients were identified. Stomach and small intestine  were the most common sites of tumor. The majority of cases  had tumor size >5 cm, 3 cases had primary and 1 case had locally advanced tumor. All the cases were surgically managed. Chemotherapy was initiated. During follow up 3 cases showed good response and 1 died due to liver metastasis. Conclusion: the incidence of GIST in Tiruchirappalli is apparently low. Surgical resection is the preferred choice of treatment



Full Text:



M.A. Sorour, M.I. Kassem, A.E. Ghazal, Gastrointestinal stromal tumors (GIST) related emergencies, Int. J. Surg. 12 (2014) 269e280.

K. De Vogelaere, M. Aerts, P. Haentjens, et al., Gastrointestinal stromal tumor of the stomach: progresses in diagnosis and treatment, Acta Gastroenterol. Belg. 76 (2013) 403e406.

N.J. Chiang, L.T. Chen, C.R. Tsai, J.S. Chang, The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998e2008: a nation-wide cancer registry-based study, BMC Cancer 14 (2014) 102.

A. Tasdemir, I. Soyuer, D. Unal, T. Artis, Prognostic value of NF-kB, CD9, and VEGF in gastrointestinal stromal tumors, Contemp. Oncol. Pozn. 17 (2013) 493e498.

R. Agarwal, M. Robson, Inherited predisposition to gastrointestinal stromal tumor, Hematol. Oncol. Clin. North Am. 23 (2009) 1e13.

M. Kumar, M.M. Goel, D. Singh, Rare case of gastrointestinal stromal tumor of the anal canal, J. Cancer Res. Ther. 9 (2013) 736e738.

M.C. Heinrich, C.D. Blanke, B.J. Druker, C.L. Corless, Review inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies, J. Clin. Oncol. 20 (2002) 1692e1703.

M. Tanaka, H. Kataoka, S. Yano, et al., Antitumor effects in gastrointestinal stromal tumors using photodynamic therapy with a novel glucose-conjugated chlorin, Mol. Cancer Ther. 13 (2014) 767e775.

G. Tryggvason, H.G. Gíslason, M.K. Magnússon, J.G. Jonasson, Gastrointestinal stromal tumors in Iceland, 1990e2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study, Int. J. Cancer 117 (2005) 289e293.

E. Nomura, A. Ioka, H. Tsukuma, Incidence of soft tissue sarcoma focusing on gastrointestinal stromal sarcoma in Osaka, Japan, during 1978e2007, Jpn. J. Clin. Oncol. 43 (2013) 841e845.

D. Cavaliere, G. Guido, E. Venturino, et al., Management of patients with gastrointestinal stromal tumors: experience from an Italian group, Tumori 91 (2005) 467e471.

M. Miettinen, J. Lasota, Review gastrointestinal stromal tumors: pathology and prognosis at different sites, Semin. Diagn. Pathol. 23 (2006) 70e83.

F.H. Barakat, H.A. Haddad, Matalka II, et al., Characteristics of gastrointestinal stromal tumors in a Middle Eastern population, Saudi Med. J. 31 (2010) 797e802.

R.Y. Bokhary, J.A. Al-Maghrabi, Gastrointestinal stromal tumors in western Saudi Arabia, Saudi Med. J. 31 (2010) 437e441.

G.M. Saied, A.M. Kensarah, Six months neoadjuvant imatinib improves resectability potential of gastric stromal tumors in Egyptian patients, Int. J. Surg. 8 (2010) 105e108.

H. Joensuu, Risk stratification of patients diagnosed with gastrointestinal stromal tumor, Hum. Pathol. 39 (2008) 1411e1419.

C.E. Woodall 3rd, G.N. Brock, J. Fan, et al., An evaluation of 2537 gastroin-testinal stromal tumors for a proposed clinical staging system, Arch. Surg. 144 (2009) 670e678.

P. Gervaz, O. Huber, P. Morel, Surgical management of gastrointestinal stromal tumours, Br. J. Surg. 96 (2009) 567e578.


  • There are currently no refbacks.